Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$161.52+0.73 (+0.45%)
Close on Nov 2, 2026Market cap $308.20BP/E 22.6Yield –
Novartis 3–4 Years by Year
3–4 Years ($M)
Novartis 3–4 Years: $802M in FY2025, up 7.5% from a year earlier. That is the highest of the 8 years on record here.
Latest, FY2025
802
Period ended Dec 31, 2025
Change on a year earlier
+7.5%
746 in FY2024
History
8 years
Since FY2018
Sources
8
Documents cited below
Where the FY2025 figure comes from
Source: Novartis Form 20-F (0001114448-26-000004) ↗
Reported in Form 20-F.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | 3–4 Years ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 802 | +7.5% | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2024 | Dec 31, 2024 | 746 | +136.1% | Novartis Form 20-F (0001370368-25-000004) ↗ |
| FY2023 | Dec 31, 2023 | 316 | +12.1% | Novartis Form 20-F (0001370368-24-000004) ↗ |
| FY2022 | Dec 31, 2022 | 282 | -55.2% | Novartis Form 20-F/A (0001370368-23-000048) ↗ |
| FY2021 | Dec 31, 2021 | 629 | +30.2% | Novartis Form 20-F (0001370368-22-000010) ↗ |
| FY2020 | Dec 31, 2020 | 483 | -33.3% | Novartis Form 20-F (0001370368-21-000006) ↗ |
| FY2019 | Dec 31, 2019 | 724 | +19.9% | Novartis Form 20-F (0001370368-20-000003) ↗ |
| FY2018 | Dec 31, 2018 | 604 | – | Novartis Form 20-F (0001370368-19-000002) ↗ |
Cite this data
StockData. (2026). Novartis 3–4 Years ($M), annual FY2018–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/rd-commit-3to4y
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.